Fen Yang Selected Research

hirsutanol A

2/2013	Hirsutanol A, a novel sesquiterpene compound from fungus Chondrostereum sp., induces apoptosis and inhibits tumor growth through mitochondrial-independent ROS production: hirsutanol A inhibits tumor growth through ROS production.
1/2012	Hirsutanol A induces apoptosis and autophagy via reactive oxygen species accumulation in breast cancer MCF-7 cells.
2/2011	Hirsutane sesquiterpenoids from the marine-derived fungus Chondrostereum sp.
7/2010	A novel sesquiterpene Hirsutanol A induces autophagical cell death in human hepatocellular carcinoma cells by increasing reactive oxygen species.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fen Yang Research Topics

Disease

47	Neoplasms (Cancer) 12/2022 - 08/2009
9	Breast Neoplasms (Breast Cancer) 01/2020 - 08/2009
7	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2009
5	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2017
5	Infections 01/2016 - 11/2010
4	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 07/2010
4	Wounds and Injuries (Trauma) 01/2018 - 02/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 02/2016
3	Esophageal Neoplasms (Esophageal Cancer) 05/2018 - 01/2016
3	Nasopharyngeal Carcinoma 03/2015 - 01/2013
2	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 07/2015
2	Inflammation (Inflammations) 12/2021 - 01/2019
2	Hypertension (High Blood Pressure) 01/2021 - 09/2016
2	Rheumatoid Arthritis 07/2018 - 11/2016
2	Blast Injuries 03/2017 - 12/2016
2	Necrosis 01/2016 - 01/2016
2	Liver Neoplasms (Liver Cancer) 01/2016 - 07/2013
2	Prostatic Neoplasms (Prostate Cancer) 04/2015 - 11/2013
2	Multiple Sclerosis 03/2015 - 09/2014
2	Mycoses (Diseases, Fungus) 11/2011 - 11/2010
1	Rabies (Hydrophobia) 01/2022
1	Pathologic Processes 02/2021
1	Parkinson Disease (Parkinson's Disease) 02/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Hypesthesia (Numbness) 01/2021
1	Neutropenia 01/2021
1	Fibrosis (Cirrhosis) 01/2021

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 12/2021 - 01/2013
8	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 07/2010
8	Long Noncoding RNAIBA 01/2020 - 01/2017
6	Biomarkers (Surrogate Marker)IBA 02/2021 - 03/2015
6	CytokinesIBA 01/2019 - 01/2014
6	Proteins (Proteins, Gene)FDA Link 09/2017 - 11/2010
4	Liposomes (Liposome)IBA 03/2021 - 02/2013
4	Biological ProductsIBA 01/2021 - 08/2014
4	hirsutanol AIBA 02/2013 - 07/2010
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2022 - 01/2021
3	Small Interfering RNA (siRNA)IBA 01/2022 - 04/2016
3	AntigensIBA 01/2021 - 09/2017
3	Phosphotransferases (Kinase)IBA 01/2021 - 08/2012
3	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2013
3	FlavonoidsIBA 07/2018 - 11/2014
3	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 02/2013
3	oridoninIBA 11/2017 - 01/2015
3	SeleniumIBA 11/2017 - 02/2013
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2017 - 02/2016
3	TOR Serine-Threonine KinasesIBA 03/2015 - 08/2012
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2015 - 08/2012
2	CurcuminIBA 12/2021 - 07/2013
2	ProdrugsIBA 10/2021 - 10/2018
2	Liraglutide FDA Link 01/2021 - 01/2016
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 09/2016
2	Interleukin-17 (Interleukin 17)IBA 01/2019 - 02/2016
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2018 - 12/2017
2	Glucagon-Like Peptide 1 (GLP 1)IBA 09/2016 - 01/2016
2	Ursolic AcidIBA 08/2016 - 01/2016
2	ChitosanIBA 08/2016 - 01/2016
2	U 0126 (UO 126)IBA 04/2016 - 08/2012
2	Mitogen-Activated Protein KinasesIBA 04/2016 - 08/2012
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2016 - 08/2012
2	QuercetinIBA 03/2016 - 08/2014
2	ApigeninIBA 01/2016 - 11/2014
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2016 - 02/2013
2	N- (1- amino- 3- (2,4- dichlorophenyl)propan- 2- yl)- 2- (2- (methylamino)pyrimidin- 4- yl)thiazole- 5- carboxamideIBA 03/2015 - 08/2012
2	dactolisibIBA 03/2015 - 01/2013
2	SesquiterpenesIBA 02/2013 - 07/2010
2	ProteomeIBA 11/2010 - 02/2010
1	Peptides (Polypeptides)IBA 12/2022
1	Death Domain ReceptorsIBA 12/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Cetuximab (Erbitux)FDA Link 01/2022
1	HydrogelsIBA 12/2021
1	chimmitecanIBA 11/2021
1	simmitecanIBA 11/2021
1	Cell-Penetrating PeptidesIBA 10/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021
1	compound 17IBA 10/2021
1	Photosensitizing Agents (Photosensitizers)IBA 02/2021
1	sinoporphyrin sodiumIBA 02/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 02/2021
1	MetalsIBA 02/2021
1	SynucleinsIBA 02/2021
1	Immunotoxins (Immunotoxin)IBA 01/2021
1	AntibodiesIBA 01/2021
1	ExotoxinsIBA 01/2021
1	Bispecific AntibodiesIBA 01/2021
1	BilirubinIBA 01/2021
1	Interleukin-13IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	Losartan (Cozaar)FDA LinkGeneric 01/2021
1	Cyclin-Dependent Kinase 5IBA 01/2021

Therapy/Procedure

16	Therapeutics 12/2022 - 02/2013
3	Photochemotherapy (Photodynamic Therapy) 12/2022 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2018
1	General Anesthesia 01/2021